# Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2

> **NCT04479163** · NA · COMPLETED · sponsor: **Fundacion Infant** · enrollment: 165 (actual)

## Conditions studied

- COVID

## Interventions

- **BIOLOGICAL:** Convalescent Plasma
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04479163
- **Lead sponsor:** Fundacion Infant
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-04
- **Primary completion:** 2020-10-25
- **Final completion:** 2020-10-25
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04479163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04479163, "Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04479163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*